BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 11287121)

  • 1. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E; Marschall HU; Winograd R; Matern S
    Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis.
    Marschall HU; Broomé U; Einarsson C; Alvelius G; Thomas HG; Matern S
    J Lipid Res; 2001 May; 42(5):735-42. PubMed ID: 11352980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
    Beuers U; Fischer S; Spengler U; Paumgartner G
    J Hepatol; 1991 Jul; 13(1):97-103. PubMed ID: 1918882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of human isoursodeoxycholic acid metabolism.
    Marschall HU; Roeb E; Yildiz Y; Busch N; Nguyen H; Purucker E; Thomas HG; Matern S
    J Hepatol; 1997 Apr; 26(4):863-70. PubMed ID: 9126801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
    Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
    Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
    Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
    Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    He H; Mennone A; Boyer JL; Cai SY
    Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
    Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
    Marschall HU; Matern H; Wietholtz H; Egestad B; Matern S; Sjövall J
    J Clin Invest; 1992 Jun; 89(6):1981-7. PubMed ID: 1602004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
    Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
    Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
    Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
    Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
    Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
    Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
    Cai SY; Mennone A; Soroka CJ; Boyer JL
    J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids.
    Marschall HU; Oppermann UC; Svensson S; Nordling E; Persson B; Höög JO; Jörnvall H
    Hepatology; 2000 Apr; 31(4):990-6. PubMed ID: 10733557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
    Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
    Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
    Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
    Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cholestasis on absorption of ursodeoxycholic acid.
    Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
    Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.